Shares of Johnson Controls International plc (NYSE: JCI) moved lower during Tuesday’s session following weak quarterly results.
Johnson Controls reported fourth-quarter FY23 sales growth of 2.7% year-on-year to $6.91 billion (+2% organically), missing the consensus of $7.09 billion. Adjusted EPS of $1.05 (+6% Y/Y) below the consensus of $1.09, according to Benzinga Pro.
Johnson Controls International shares fell 6.2% to $53.05 on Tuesday.
Here are some other stocks moving in today's mid-day session.
Gainers
Aditxt, Inc. (NASDAQ: ADTX) shares jumped 140.5% to $9.14 after the company entered into definitive agreement to acquire Evofem Biosciences.
C4 Therapeutics, Inc. (NASDAQ: CCCC) gained 57.5% to $1.8590 after the company announced a license and research collaboration with Merck to discover and develop degrader-antibody conjugates.
Candel Therapeutics, Inc. (NASDAQ: CADL) shares climbed 48% to $1.24 after the company announced it received FDA Fast Track Designation for CAN-2409 in pancreatic cancer.
Icosavax, Inc. (NASDAQ: ICVX) rose climbed 47.1% to $15.43 after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion. Concurrently, Icosavax released topline interim results for its Phase 2 study of IVX-A12, a combination virus-like particle (VLP) vaccine candidate targeting both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV).
Clean Earth Acquisitions Corp. (NASDAQ: CLIN) gained 41.3% to $6.71. Clean Earth and Alternus Energy announced continuation of business combination close process.
Bruush Oral Care Inc. (NASDAQ: BRSH) shares rose 24.1% to $0.2022 after gaining over 5% on Monday.
Spectaire Holdings Inc. (NASDAQ: SPEC) gained 23.7% to ...
Related tickers: BRSH, SBOW, HPCO, CMND, NOGN, BON, ACHV, HRYU, CLNE, ADTX, PAPL, EGLE, HCDI, CAVA, ORCL, BQ, SVMH, SPEC, ADEX, AAGR, JCI, GOTU, ODC, LCID, ICG, CADL, GGE, ICVX, CCCC, INAB, CLIN, IONM, ACLX, GPRO, KNTK, APPS, IXHL, BLBD.
Read Full Article
